The global market for contract development and manufacturing organisations (CDMOs) is set to grow at a CAGR of 6.1% between 2022 and 2030, according to a report by Grand View Research. A lot of this growth is driven by the increasing demand for new oncology drugs. CDMOs offer a variety of services to pharmaceutical companies, including drug development, manufacturing, and supply chain management.

UK retailer Co-Op says systems now running normally after cyber incident – CNA
UK retailer Co-Op has announced that its systems are functioning normally following a recent cyber incident. The company experienced disruptions but has resolved the issues